Study Synopsis • The findings will impact the interventional treatment of High Bleeding Risk patients. • Data from 732 patients across 11 Dutch centres For immediate release SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on innovative patient care in cardiovascular segment, today announced positive